• Magazine
  • ENEWS
  • SUBSCRIBE
  • WEBINARS
  • PODCASTS
  • EBOOKS
    1. Home

    GW Readies Cannabis-based Drug for EU Market

    July 17, 2009
    GW Pharmaceutical has announced that its U.K. manufacturing facility has received regulatory approval, in advance of its launch of cannabis-based Sativex into the European market. A blast from the past: We caught up with GW a few years ago to discuss the process by which cannabis plants are turned into active ingredients.

     

    GW Pharmaceutical has announced that its U.K. manufacturing facility has received regulatory approval, in advance of its launch of cannabis-based Sativex into the European market. A blast from the past: We caught up with GW a few years ago to discuss the process by which cannabis plants are turned into active ingredients.

    --PWT

    About the Author

    pharmamanufacturing | pharmamanufacturing